OpenAI Executives Adjust Roles: Simo on Medical Leave, COO Transition, CMO Departure for Cancer Treatment

According to monitoring by 1M AI News, Fidji Simo, CEO of OpenAI’s AGI deployment division, announced that she will take a few weeks of medical leave due to worsening symptoms of Postural Orthostatic Tachycardia Syndrome (POTS). In an internal memo, she stated, “I repeatedly postponed medical examinations and new therapies just to focus entirely on work and not miss a single day, but it seems I have indeed pushed myself too far.” This marks her first leave since joining OpenAI in August of last year. During her absence, co-founder and president Greg Brockman will take over product responsibilities, while CSO Jason Kwon, CFO Sarah Friar, and Chief Revenue Officer Denise Dresser will jointly manage daily operations. On the same day, COO Brad Lightcap officially transitioned to a new role, no longer overseeing daily operations, and will focus on special projects, with a primary task of advancing OpenAI’s collaboration with private equity firms and selling AI tools to their portfolio companies, reporting directly to CEO Sam Altman. OpenAI stated that there are no plans to appoint a new COO, and Lightcap’s previous business responsibilities will be taken over by former Slack CEO Dresser. Chief Marketing Officer Kate Rouch is leaving due to cancer treatment, planning to return in a reduced capacity after recovery; former Meta CMO Gary Briggs, who has served as OpenAI’s marketing advisor for the past year, will temporarily oversee marketing until a successor is found. These three changes were announced on the same day, a sensitive timing. Just this week, OpenAI completed a $12.2 billion funding round at a valuation of $852 billion, and Altman had previously indicated internally that Simo would lead OpenAI’s earnings call following its IPO. Simo has been a key driver of product integration at OpenAI for eight months, leading initiatives from shutting down Sora to integrating ChatGPT and Codex to create a ‘super app.’ Her short-term absence, combined with the COO position being vacant, adds uncertainty to the executive team’s stability narrative during the IPO window.